SEC Form 8-K Summary
Registrant and period: Wealthbridge Acquisition Limited, a British Virgin Islands special purpose acquisition company, filed a Form 8-K reporting events dated October 28, 2019; the report was signed November 1, 2019. The filing concerns the proposed acquisition of Scienjoy Inc. and is relevant to the subsequent Scienjoy Holding Corp. transaction.
Business Context and Transaction
On October 28, 2019, Wealthbridge entered into a share exchange agreement with Lavacano Holdings Limited, WBY Entertainment Holdings Ltd. and Scienjoy Inc. Wealthbridge agreed to acquire 100% of Scienjoy in exchange for approximately 16.4 million Wealthbridge ordinary shares.
- Approximately 1.64 million shares, or 10% of the closing consideration, will be placed in escrow to secure seller indemnification obligations.
- The sellers may receive up to 9.0 million additional earnout shares based on Scienjoy’s pre-tax net income for 2019, 2020 and 2021, or based on specified post-closing share-price targets.
- The transaction remains subject to shareholder approval, Nasdaq listing requirements, regulatory and other customary closing conditions.
Financial Metrics and Liquidity
The filing does not provide clear values for revenue, net income, operating cash flow, margins, debt, cash balances, liquidity or other historical financial metrics for Scienjoy or Wealthbridge.
The earnout thresholds require Scienjoy pre-tax net income of at least:
| Year | Pre-tax net income threshold | Potential shares |
|---|---|---|
| 2019 | US$20.9 million or RMB140.0 million | 3.0 million |
| 2020 | US$28.3 million or RMB190.0 million | 3.0 million |
| 2021 | US$35.0 million or RMB235.0 million | 3.0 million |
Additional earnout shares may be issued if Wealthbridge’s stock price exceeds $15, $20 or $25 for specified periods after closing. The filing text does not clearly state the transaction’s enterprise value, post-closing equity value, financing arrangements or pro forma ownership percentages.
Material Changes and Key Terms
- The agreement establishes the proposed business combination; closing had not occurred as of the filing.
- Scienjoy and Wealthbridge agreed to operate in the ordinary course before closing and provide access to books, records and information.
- Scienjoy must provide financial statements required for Wealthbridge’s SEC filings, including audited financial statements for 2016, 2017 and 2018.
- The sellers will receive registration rights for the shares issued in the transaction.
- The sellers’ closing shares will generally be subject to a 365-day lock-up, subject to specified exceptions.
- A six-year voting agreement is contemplated, under which the sellers may designate five directors and Wealthbridge’s sponsor may designate two directors, subject to the agreement’s terms.
- Seller indemnification obligations are subject to a $50,000 aggregate threshold and are capped at the value of the 1.64 million escrow shares, payable through cancellation of Wealthbridge shares.
Outlook, Risks and Contingencies
Management provided forward-looking statements regarding the proposed transaction, anticipated synergies, integration, revenue opportunities, future performance and transaction timing. These statements are not guarantees of performance.
- The transaction could fail to close if shareholder approval, regulatory approvals, Nasdaq listing approval, financial statement delivery or other conditions are not satisfied.
- The agreement may be terminated if required audited financial statements are not delivered by March 15, 2020, the proxy statement is not filed by March 31, 2020, or closing has not occurred by specified deadlines extending through September 30, 2020.
- Other risks include material adverse changes, integration difficulties, inability to achieve synergies, financing risks, customer or employee retention issues, disruption of management attention and possible adverse effects on Wealthbridge’s stock price.
- The filing states that additional risk factors will be included in the proxy statement and other SEC filings.
Investor Verification Checklist
- Verify the definitive share exchange agreement, omitted schedules and closing conditions.
- Review Scienjoy’s audited financial statements and confirm historical revenue, profitability, cash flow, debt and liquidity.
- Confirm the transaction’s final valuation, ownership dilution, financing and trust-account treatment.
- Assess whether the 2019–2021 earnout thresholds are achievable and understand the effect of potential earnout share issuance.
- Confirm shareholder, regulatory and Nasdaq approvals and whether the transaction ultimately closed.
- Review the definitive proxy statement for participant interests, related-party matters, voting arrangements and detailed risk factors.